Off-Label Drug Use in Aquaculture

Off-label use means administering a veterinary medicine in a way not covered by its approved label: a different species, dose, route, duration, or indication, for example using a product licensed for cattle to treat a bacterial gill disease in tilapia. Because few pharmaceuticals are specifically authorized for minor fish species, off-label prescribing is common, but it is tightly regulated. In the EU and US it is permitted only under veterinary prescription with conditions: no authorized alternative may exist, an appropriate withdrawal period must be extended beyond the labeled one, and use must be documented in the farm health plan. Routine off-label use as a production shortcut, especially of banned substances like chloramphenicol or fluoroquinolones at unapproved doses, creates severe residue and antimicrobial-resistance risk and can trigger export rejection under national monitoring programs. From a management standpoint, reliance on off-label drugs signals a gap in preventive health; certified farms minimize it through vaccination, water-quality control, and rapid diagnostics, keeping off-label prescriptions as exceptional, veterinarian-supervised events with extended withdrawal compliance.